Physician profile
Phillip A Myers
NPI 1518111426
$1,540.06
in general payments reported to CMS, 2019-2025
8 companies · $76.85 in 2025
The $76.85 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $695 · 2022: $25.97 · 2023: $299 · 2024: $443 · 2025: $76.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $819.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $819.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urgo Medical North America, LLC | $482.17 | 2023-2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4 |
| Bard Peripheral Vascular, INC. | $453.62 | 2021-2023 | Venclose Maven Catheter |
| Smith+Nephew, INC. | $287.28 | 2021-2025 | Collagenase Santyl |
| Medtronic, INC. | $154.37 | 2023-2025 | Venaseal, Closurefast |
| Tactile Systems Technology INC | $117.92 | 2021 | |
| Janssen Pharmaceuticals, INC | $25.97 | 2022 | |
| Abbott Laboratories | $18.73 | 2025 | Perclose Prostyle |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phillip Myers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.